Compare · head to head
Glaukos vs PROCEPT BioRobotics
Glaukos ranks higher overall — 360 rank 31 vs 19.
Glaukos leads on Growth (70 vs 53) and Sentiment (58 vs 40). PROCEPT BioRobotics leads on Safety (50 vs 29). The two are close on Value and Quality.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| Size | Medium | Medium |
| ISIN | US3773221029 | US74276L1052 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 31 | 19 |
| Value | 35 | 39 |
| Quality | 37 | 33 |
| Growth | 70 | 53 |
| Safety | 29 | 50 |
| Sentiment | 58 | 40 |
| Quality details | ||
| Profitability | 22 | 24 |
| Cash Truth | 51 | 43 |
Glaukos vs IRIDEXGlaukos vs Sight SciencesGlaukos vs Edwards LifesciencesGlaukos vs Microbot MedicalAdd a third stock →
Full analyses: Glaukos · PROCEPT BioRobotics
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100